Martingale Asset Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,398
Closed -$85K 792
2023
Q3
$85K Hold
1,398
﹤0.01% 771
2023
Q2
$92K Hold
1,398
﹤0.01% 789
2023
Q1
$88.9K Hold
1,398
﹤0.01% 808
2022
Q4
$194K Hold
1,398
﹤0.01% 795
2022
Q3
$178K Buy
1,398
+2
+0.1% +$226 ﹤0.01% 788
2022
Q2
$116K Hold
1,396
﹤0.01% 823
2022
Q1
$136K Hold
1,396
﹤0.01% 789
2021
Q4
$279K Sell
1,396
-736
-35% -$174K ﹤0.01% 752
2021
Q3
$528K Buy
2,132
+1,112
+109% +$318K 0.01% 659
2021
Q2
$423K Buy
1,020
+479
+89% +$190K ﹤0.01% 637
2021
Q1
$212K Sell
541
-533
-50% -$262K ﹤0.01% 809
2020
Q4
$602K Sell
1,074
-131
-11% -$83K 0.01% 571
2020
Q3
$842K Buy
1,205
+62
+5% +$48.4K 0.01% 683
2020
Q2
$904K Buy
+1,143
New +$862K 0.01% 757
2018
Q2
Sell
-1,028
Closed -$2.27M 979
2018
Q1
$2.27M Hold
1,028
0.03% 492
2017
Q4
$2.37M Sell
1,028
-100
-9% -$203K 0.03% 492
2017
Q3
$2.01M Sell
1,128
-46
-4% -$64.3K 0.03% 551
2017
Q2
$1.6M Sell
1,174
-139
-11% -$168K 0.02% 617
2017
Q1
$1.55M Buy
1,313
+8
+0.6% +$8.16K 0.02% 610
2016
Q4
$1.04M Sell
1,305
-12
-0.9% -$9.53K 0.01% 698
2016
Q3
$1.16M Buy
1,317
+220
+20% +$159K 0.02% 657
2016
Q2
$616K Buy
+1,097
New +$621K 0.01% 629

Other funds holding BLUE

Martingale Asset Management's BLUE Position: Q4 2023 in Review

Martingale Asset Management sold out of bluebird bio (BLUE) in Q4 2023, closing a stake of 1,398 shares — an estimated $85K sold.

Martingale Asset Management first reported a position in BLUE in Q2 2016 and held it in 22 quarters. The position peaked at $2.37M in Q4 2017. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.

  • Martingale Asset Management reported no remaining bluebird bio position as of Q4 2023 after selling out during the quarter.
  • Martingale Asset Management sold 1,398 bluebird bio shares in Q4 2023, an estimated $85K.
  • Martingale Asset Management first reported a position in bluebird bio in Q2 2016 and held it in 22 quarters.
  • Martingale Asset Management's bluebird bio position peaked at $2.37M in Q4 2017.
  • 187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.

Based on Martingale Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.